Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01406691 · ClinicalTrials.gov registry record · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
A Phase 4 study of Delayed Sleep Phase Disorder, sponsored by Stanford University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01406691: Recruiting Phase 4 study of Delayed Sleep Phase Disorder, sponsored by Stanford University.
NCT01406691 is a Phase 4 study of Delayed Sleep Phase Disorder that is actively recruiting participants, run by Stanford University. The registered enrollment target is 20 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01406691, a Phase 4 study of Delayed Sleep Phase Disorder, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Delayed Sleep Phase Disorder (DSPD) is a sleep disruption that commonly occurs in teens and manifests as a difficulty in waking up in the morning, going to sleep early enough at night, and daytime disturbances such as depression, fatigue, and restlessness. The purpose of this study is to determine if brief flashes of light, that are scheduled to occur during sleep, are effective in treating DSPD.
Primary Outcome
Determined by questionnaire (Adolescent Sleep Wake Scale)
Conditions Studied
Interventions
- DEVICE Flashes
Study Locations (1)
California
- Stanford University - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-12 |
| Est. Completion | 2028-09 |
| Phase | Phase 4 |
What NCT01406691 shows while recruiting
NCT01406691 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Delayed Sleep Phase Disorder appearing as the primary indexed condition, and to 1 intervention - of which Flashes is the first listed.
NCT01406691 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01406691 about?
NCT01406691 is a clinical study titled "Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)". Delayed Sleep Phase Disorder (DSPD) is a sleep disruption that commonly occurs in teens and manifests as a difficulty in waking up in the morning, going to sleep early enough at night, and daytime disturbances such as depression, fatigue, and restlessness. The purpose of this study is to determine i...
What is the current status of trial NCT01406691?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2013-12. Estimated completion is 2028-09.
What conditions does trial NCT01406691 study?
This clinical trial studies the following conditions: Delayed Sleep Phase Disorder.
What interventions are being tested in trial NCT01406691?
The interventions under investigation include: Flashes (DEVICE).
Who is sponsoring clinical trial NCT01406691?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01406691 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01406691's enrollment target sits among peer trials
20 1753rd of 2000 higher than 168 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01630850 · 20 participants · NA
Islet Transplantation in Patients With "Brittle" Type I Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia